Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/26/24 17:38 | 11/25/24 | CYTK | Health | Drug | Pharmaceutical Preparations | Wierenga Wendall | CA | D | 2 | S.d | -270 | 51.93 | 0 | -5 | 25 | D | ||||||||||||||||
11/19/24 16:16 | 11/18/24 | CYTK | Health | Drug | Pharmaceutical Preparations | Blum Robert I | CA | DO | P,CEO | 6 | S.d | -1,615 | 53.83 | 0 | -30 | 402 | D | |||||||||||||||
11/13/24 17:04 | 11/12/24 | CYTK | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 6 | S.d | -2,361 | 55.00 | 0 | -43 | 123 | D | |||||||||||||||
9/9/24 16:05 | 9/9/24 | CYTK | Health | Drug | Pharmaceutical Preparations | Parshall B Lynne | CA | D | 1 | S.d | -275 | 54.92 | 0 | -5 | 21 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |